Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

The ORF3 protein of porcine circovirus type 2 interacts with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral infection.

Liu J, Zhu Y, Chen I, Lau J, He F, Lau A, Wang Z, Karuppannan AK, Kwang J.

J Virol. 2007 Sep;81(17):9560-7. Epub 2007 Jun 20.

PMID:
17581998
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Chen D, Kon N, Li M, Zhang W, Qin J, Gu W.

Cell. 2005 Jul 1;121(7):1071-83.

PMID:
15989956
[PubMed - indexed for MEDLINE]
Free Article
3.

Regulation of p53 and MDM2 activity by MTBP.

Brady M, Vlatkovic N, Boyd MT.

Mol Cell Biol. 2005 Jan;25(2):545-53.

PMID:
15632057
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.

Landrette SF, Kuo YH, Hensen K, Barjesteh van Waalwijk van Doorn-Khosrovani S, Perrat PN, Van de Ven WJ, Delwel R, Castilla LH.

Blood. 2005 Apr 1;105(7):2900-7. Epub 2004 Dec 7.

PMID:
15585652
[PubMed - indexed for MEDLINE]
Free Article
5.

Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer.

Duan W, Gao L, Druhan LJ, Zhu WG, Morrison C, Otterson GA, Villalona-Calero MA.

J Natl Cancer Inst. 2004 Nov 17;96(22):1718-21.

PMID:
15547185
[PubMed - indexed for MEDLINE]
Free Article
6.

Yin Yang 1 is a negative regulator of p53.

Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, Shi Y.

Cell. 2004 Jun 25;117(7):859-72.

PMID:
15210108
[PubMed - indexed for MEDLINE]
Free Article
7.

The ubiquitin ligase COP1 is a critical negative regulator of p53.

Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM.

Nature. 2004 May 6;429(6987):86-92. Epub 2004 Apr 21.

PMID:
15103385
[PubMed - indexed for MEDLINE]
8.

Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.

Castilla LH, Perrat P, Martinez NJ, Landrette SF, Keys R, Oikemus S, Flanegan J, Heilman S, Garrett L, Dutra A, Anderson S, Pihan GA, Wolff L, Liu PP.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4924-9. Epub 2004 Mar 24.

PMID:
15044690
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity.

Ravi K, Brennan LA, Levic S, Ross PA, Black SM.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2619-24.

PMID:
14983058
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome.

Logan IR, Sapountzi V, Gaughan L, Neal DE, Robson CN.

J Biol Chem. 2004 Mar 19;279(12):11696-704. Epub 2003 Dec 29.

PMID:
14701804
[PubMed - indexed for MEDLINE]
Free Article
11.

Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y.

Mol Cell Biol. 2003 Dec;23(23):8902-12.

PMID:
14612427
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Dimerization of the human E3 ligase CHIP via a coiled-coil domain is essential for its activity.

Nikolay R, Wiederkehr T, Rist W, Kramer G, Mayer MP, Bukau B.

J Biol Chem. 2004 Jan 23;279(4):2673-8. Epub 2003 Nov 10.

PMID:
14610072
[PubMed - indexed for MEDLINE]
Free Article
13.

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S.

Cell. 2003 Mar 21;112(6):779-91.

PMID:
12654245
[PubMed - indexed for MEDLINE]
Free Article
14.

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

Brooks CL, Gu W.

Curr Opin Cell Biol. 2003 Apr;15(2):164-71. Review.

PMID:
12648672
[PubMed - indexed for MEDLINE]
15.

C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer.

Hattori T, Ohoka N, Inoue Y, Hayashi H, Onozaki K.

Oncogene. 2003 Mar 6;22(9):1273-80.

PMID:
12618752
[PubMed - indexed for MEDLINE]
16.

Tumor suppression by Ink4a-Arf: progress and puzzles.

Lowe SW, Sherr CJ.

Curr Opin Genet Dev. 2003 Feb;13(1):77-83. Review.

PMID:
12573439
[PubMed - indexed for MEDLINE]
17.

The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities.

Hensen K, Van Valckenborgh IC, Kas K, Van de Ven WJ, Voz ML.

Cancer Res. 2002 Mar 1;62(5):1510-7.

PMID:
11888928
[PubMed - indexed for MEDLINE]
Free Article
18.

PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms.

Gisselsson D, Hibbard MK, Dal Cin P, Sciot R, Hsi BL, Kozakewich HP, Fletcher JA.

Am J Pathol. 2001 Sep;159(3):955-62.

PMID:
11549588
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E, Oren M.

Genes Dev. 2001 May 1;15(9):1067-77.

PMID:
11331603
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.

Li L, Liao J, Ruland J, Mak TW, Cohen SN.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1619-24.

PMID:
11172000
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk